Postoperative mortality rates were twice as high (1.4% vs 0.73%) for patients having hip and knee replacements in hospitals that were the least specialized in orthopedic surgery compared to those that were the most specialized in a study published in the British Medical Journal.
Patients at the most specialized hospitals had lower rates of serious complications such as infections, deep vein thrombosis, and myocardial infarctions.
The findings were based on Medicare data of nearly 1.3 million patients who had hip or knee replacements at 3,818 US hospitals between 2001 and 2005.
—Hagen T P, Vaughan-Sarrazin M S, Cram P. Brit Med J. 2010;340:c165.
Though more patients are asking for it and surgeons are learning the technique, robotic-assisted prostate surgery has not been proven to have better outcomes than open surgery and is more expensive, reports the Feb 13 New York Times. Last year, 86% of men who had prostate cancer surgery had robot-assisted procedures, yet no large studies are planned or underway to see if robot-assisted prostate surgery gives better, worse, or equivalent long-term cancer control than the traditional methods.
Researchers say the robot is an example of how technology can spread long before investigators know whether it is worthwhile. Patients may end up making life-changing decisions based on little more than assertive marketing or surgeon preference.
—www.nytimes.com (registration required)
On March 3, Kimberly-Clark Health Care received Food and Drug Administration clearance for use of its Kimguard One-Step Sterilization Wrap in conjunction with Steris Corporation’s AMSCO V-Pro sterilization systems. The company says the wrap provides the protection of double wrapping in a single step, which cuts the time to open or wrap sequential wrapping in half. The V-Pro 1 and V-Pro 1 Plus Low Temperature Sterilization Systems process heat and moisture-sensitive devices using vaporized hydrogen peroxide.
Adverse effects caused by metal-on-metal implants for total hip replacements and resurfacing procedures have prompted some orthopedic surgeons to reduce or stop the use of these devices, according to the March 3 New York Times. In some cases, the devices wear quickly, generating high volumes of metallic debris that is absorbed into the body. This can spark inflammatory reactions that cause groin pain, soft-tissue destruction, and destruction of bone. Some devices are requiring replacement within 1 to 2 years rather than the standard 15 years.
Metal-on-metal implants are used in approximately one-third of hip replacements, and studies estimate 1% to 3% of recipients could be affected by the problem.
All major orthopedic companies sell the metal-on-metal implants. Several companies said in statements that the implants did not pose a significant risk and that the incidence of metal debris problems was extremely low.
—www.nytimes.com (registration required)